**Core Concept**
The hypothalamic-pituitary-adrenal (HPA) axis suppression caused by long-term steroid therapy can be managed using alternate day therapy with corticosteroids. This approach aims to mimic the body's natural cortisol production pattern, reducing the risk of HPA axis suppression.

**Why the Correct Answer is Right**
Alternate day therapy with corticosteroids is effective in maintaining HPA axis function because it allows the body to recover from the suppressive effects of steroids during the off-days. This approach is particularly useful for long-term management of conditions like asthma, rheumatoid arthritis, and chronic obstructive pulmonary disease (COPD). The effectiveness of alternate day therapy depends on the type of steroid used, as some have a longer half-life than others.

**Why Each Wrong Option is Incorrect**
**Option A:** Prednisolone - Prednisolone has a relatively long half-life (about 3-4 hours), making it suitable for alternate day therapy.

**Option B:** Methylprednisolone - Methylprednisolone is a long-acting steroid with a half-life of around 18-36 hours, which makes it suitable for alternate day therapy.

**Option C:** Dexamethasone - Dexamethasone is a long-acting steroid with a very long half-life (about 36-72 hours), making it unsuitable for alternate day therapy due to its prolonged suppressive effects on the HPA axis.

**Clinical Pearl / High-Yield Fact**
When choosing a corticosteroid for alternate day therapy, it's essential to consider the drug's half-life and duration of action to minimize HPA axis suppression. A shorter half-life and a more natural cortisol production pattern are preferred.

**Correct Answer:** C. Dexamethasone is unsuitable for alternate day therapy due to its prolonged suppressive effects on the HPA axis.